Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 700
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03020992 | A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU | ||
| NCT00612859 | Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type) | ||
| NCT00498186 | Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS) | ||
| NCT00150800 | This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment | ||
| NCT01081912 | Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain | ||
| NCT01394224 | Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects | ||
| NCT02451748 | IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA | ||
| NCT00279617 | Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks | ||
| NCT00861068 | A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN). | ||
| NCT01506882 | An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy | ||
| NCT00490035 | Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures | ||
| NCT00160589 | LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) | ||
| NCT00220415 | A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization | ||
| NCT02161185 | A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters | ||
| NCT02905006 | Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis | ||
| NCT01375387 | Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males | ||
| NCT00596752 | Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV | ||
| NCT02804763 | A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus | ||
| NCT01016834 | Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine | ||
| NCT00296192 | Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms | ||
| NCT02926898 | A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome | ||
| NCT01236001 | Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older | ||
| NCT04596995 | A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) | ||
| NCT02276053 | Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors | ||
| NCT00368251 | Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults | ||
| NCT00699283 | A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures | ||
| NCT04242446 | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa | ||
| NCT02408549 | Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures | ||
| NCT02075697 | Spanish Registry of Systemic Treatments in Psoriasis | ||
| NCT00152490 | A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo) | ||
| NCT03467113 | A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol | ||
| NCT00333788 | Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease | ||
| NCT01519791 | A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis | ||
| NCT02222740 | A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain | ||
| NCT06425549 | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis | ||
| NCT00357669 | Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults | ||
| NCT03010527 | A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis | ||
| NCT06961747 | A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women | ||
| NCT01229735 | Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures | ||
| NCT04436640 | A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis | ||
| NCT00566046 | Prevention of Post-traumatic Seizures With Levetiracetam | ||
| NCT02552212 | Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS | ||
| NCT00510783 | IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures | ||
| NCT01723904 | A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease | ||
| NCT00544154 | Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis | ||
| NCT06312566 | A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study Participants | ||
| NCT01262794 | Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects | ||
| NCT04976322 | A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus | ||
| NCT01339559 | Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy | ||
| NCT01338896 | Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations |
